date:Oct 31, 2018
genome editing used in producing human products, including those for use in xenotransplantation, and how these products will be regulated.
Were also piloting a new Veterinary Innovation Program (VIP) for developers of intentionally genetically altered (IGA) animals and animal cells, tissues and cell- or tissue-based products (ACTPs) that are seeking the FDAs approval of a new animal drug application. The program will provide intensive assistance for developers of IGA animals or ACTPs that benef